Recent progress in the genetics of motor neuron disease

European Journal of Medical Genetics

Volumn 57, Issue 2-3, 2014, Pages 103-112

  Finsterer, Josef ^a   Burgunder, Jean Marc ^b  

^a KRANKENANSTALT RUDOLFSTIFTUNG   (Austria)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Anterior horn cell; Genetics; Hereditary; Motor neuron disease; Nerve conduction; Neuropathy

Indexed keywords

ANGIOGENIN; ATAXIN 2; COPPER ZINC SUPEROXIDE DISMUTASE; DEXTRO AMINO ACID OXIDASE; DYNACTIN; DYNACTIN 1; EPIDERMAL GROWTH FACTOR RECEPTOR 4; ERLIN2 PROTEIN; FUSED IN SARCOMA PROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A1; OPTINEURIN; PROFILIN; PROFILIN 1 PROTEIN; PROTEIN; SENATAXIN PROTEIN; SEQUESTOSOME PROTEIN 1; SIGMA OPIATE RECEPTOR; SIGMA RECEPTOR 1; SPATACSIN PROTEIN; SURVIVAL MOTOR NEURON PROTEIN 1; SYNAPTOBREVIN; TAR DNA BINDING PROTEIN; UBIQUILIN 2 PROTEIN; UNCLASSIFIED DRUG; VALOSIN CONTAINING PROTEIN;

ADULT DISEASE; ALLGROVE SYNDROME; ALS2 GENE; AMYOTROPHIC LATERAL SCLEROSIS; BICD2 GENE; BROWN VIALETTO VAN LARE SYNDROME; C9ORF72 GENE; DISEASE COURSE; FAMILIAL AMYOTROPHIC LATERAL SCLEROSIS; FAMILIAL DISEASE; FIG4 GENE; GENE; GENE MUTATION; GENETIC ANALYSIS; GRN GENE; HUMAN; JUVENILE; KENNEDY DISEASE; MOTOR NEURON DISEASE; NONHUMAN; OUTCOME ASSESSMENT; PHENOTYPE; REVIEW; SANDHOFF DISEASE; SPASTIC PARAPLEGIA; SPG11 GENE; SPINAL MUSCULAR ATROPHY; SPORADIC AMYOTROPHIC LATERAL SCLEROSIS; UNC13A GENE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; MUTATION;

GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MOTOR NEURON DISEASE; MUTATION;

EID: 84897108010     PISSN: 17697212     EISSN: 18780849     Source Type: Journal    
DOI: 10.1016/j.ejmg.2014.01.002     Document Type: Review

References (110)

1. Alavi A., Nafissi S., Rohani M., Shahidi G., Zamani B., Shamshiri H., et al. Repeat expansion in C9ORF72 is not a major cause of amyotrophic lateral sclerosis among Iranian patients. Neurobiol Aging 2014, 35:267.e1-267.e7.
2. Al-Saif A., Bohlega S., Al-Mohanna F. Loss of ERLIN2 function leads to juvenile primary lateral sclerosis. Ann Neurol 2012, 72:510-516.
3. Andersen P.M., Al-Chalabi A. Clinical genetics of amyotrophic lateral sclerosis: what do we really know?. Nat Rev Neurol 2011, 7:603-615.
4. Armstrong G.A., Drapeau P. Calcium channel agonists protect against neuromuscular dysfunction in a genetic model of TDP-43 mutation in ALS. JNeurosci 2013, 33:1741-1752.
5. Arning L., Epplen J.T., Rahikkala E., Hendrich C., Ludolph A.C., Sperfeld A.D. The SETX missense variation spectrum as evaluated in patients with ALS4-like motor neuron diseases. Neurogenetics 2013, 14:53-61.
6. Arnold E.S., Ling S.C., Huelga S.C., Lagier-Tourenne C., Polymenidou M., Ditsworth D., et al. ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43. Proc Natl Acad Sci USA 2013, 110:E736-E745.
7. Ash P.E., Bieniek K.F., Gendron T.F., Caulfield T., Lin W.L., Dejesus-Hernandez M., et al. Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS. Neuron 2013, 77:639-646.
8. Ayers J., Lelie H., Workman A., Prudencio M., Brown H., Fromholt S., et al. Distinctive features of the D101N and D101G variants of superoxide dismutase 1; two mutations that produce rapidly progressing motor neuron disease. J.Neurochem 2014, 128:305-314.
9. Basso M., Pozzi S., Tortarolo M., Fiordaliso F., Bisighini C., Pasetto L., et al. Mutant copper-zinc superoxide dismutase (SOD1) induces protein secretion pathway alterations and exosome release in astrocytes: implications for disease spreading and motor neuron pathology in amyotrophic lateral sclerosis. JBiol Chem 2013, 288:15699-15711.
10. Bosch A.M., Stroek K., Abeling N.G., Waterham H.R., Ijlst L., Wanders R.J. The Brown-Vialetto-Van Laere and Fazio Londe syndrome revisited: natural history, genetics, treatment and future perspectives. Orphanet J Rare Dis 2012 Oct 29, 7:83. 10.1186/1750-1172-7-83.
11. Branchu J., Biondi O., Chali F., Collin T., Leroy F., Mamchaoui K., et al. Shift from extracellular signal-regulated kinase to AKT/cAMP response element-binding protein pathway increases survival-motor-neuron expression in spinal-muscular-atrophy-like mice and patient cells. JNeurosci 2013, 33:4280-4294.
12. Byrne S., Elamin M., Bede P., Shatunov A., Walsh C., Corr B., et al. Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study. Lancet Neurol 2012, 11:232-240.
13. Calini D., Corrado L., Del Bo R., Gagliardi S., Pensato V., Verde F., et al. Analysis of hnRNPA1, A2/B1, and A3 genes in patients with amyotrophic lateral sclerosis. Neurobiol Aging 2013, 34:2695.e11-2695.e12.
14. Cannon A., Fujioka S., Rutherford N.J., Ferman T.J., Broderick D.F., Boylan K.B., et al. Clinicopathologic variability of the GRN A9D mutation, including amyotrophic lateral sclerosis. Neurology 2013, 80:1771-1777.
15. Cerami C., Marcone A., Galimberti D., Zamboni M., Fenoglio C., Serpente M., et al. Novel evidence of phenotypical variability in the hexanucleotide repeat expansion in chromosome 9. JAlzheimers Dis 2013, 35:455-462.
16. Chen S., Sayana P., Zhang X., Le W. Genetics of amyotrophic lateral sclerosis: an update. Mol Neurodegener 2013, 8:28.
17. Chesi A., Staahl B.T., Jovičić A., Couthouis J., Fasolino M., Raphael A.R., et al. Exome sequencing to identify de novo mutations in sporadic ALS trios. Nat Neurosci 2013, 16:851-855.
18. Chiò A., Borghero G., Restagno G., Mora G., Drepper C., Traynor B.J., et al. Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72. Brain 2012, 135:784-793.
19. Chiò A., Mora G., Restagno G., Brunetti M., Ossola I., Barberis M., et al. UNC13A influences survival in Italian amyotrophic lateral sclerosis patients: a population-based study. Neurobiol Aging 2013, 34:357.e1-357.e5.
20. Chow C.Y., Landers J.E., Bergren S.K., Sapp P.C., Grant A.E., Jones J.M., et al. Deleterious variants of FIG4, a phosphoinositide phosphatase, in patients with ALS. Am J Hum Genet 2009, 84:85-88.
21. Çobanoǧlu G., Ozansoy M., Başak A.N. Are alsin and spartin novel interaction partners?. Biochem Biophys Res Commun 2012, 427:1-4.
22. Conforti F.L., Spataro R., Sproviero W., Mazzei R., Cavalcanti F., Condino F., et al. Ataxin-1 and ataxin-2 intermediate-length PolyQ expansions in amyotrophic lateral sclerosis. Neurology 2012, 79:2315-2320.
23. Coon E.A., Daube J.R., Dejesus-Hernandez M., Adeli A., Savica R., Parisi J.E., et al. Clinical and electrophysiologic variability in amyotrophic lateral sclerosis within a kindred harboring the C9ORF72 repeat expansion. Amyotroph Lateral Scler Front Degener 2013, 14:132-137.
24. Corrado L., Carlomagno Y., Falasco L., Mellone S., Godi M., Cova E., et al. Anovel peripherin gene (PRPH) mutation identified in one sporadic amyotrophic lateral sclerosis patient. Neurobiol Aging 2011, 32:552.e1-552.e6.
25. Cox L.E., Ferraiuolo L., Goodall E.F., Heath P.R., Higginbottom A., Mortiboys H., et al. Mutations in CHMP2B in lower motor neuron predominant amyotrophic lateral sclerosis (ALS). PLoS One 2010 Mar 24, 5(3):e9872. 10.1371/journal.pone.0009872.
26. Czell D., Andersen P.M., Neuwirth C., Morita M., Weber M. Progressive aphasia as the presenting symptom in a patient with amyotrophic lateral sclerosis with a novel mutation in the OPTN gene. Amyotroph Lateral Scler Front Degener 2013, 14:138-140.
27. Daigle J.G., Lanson N.A., Smith R.B., Casci I., Maltare A., Monaghan J., et al. RNA-binding ability of FUS regulates neurodegeneration, cytoplasmic mislocalization and incorporation into stress granules associated with FUS carrying ALS-linked mutations. Hum Mol Genet 2013, 22:1193-1205.
28. Daoud H., Dobrzeniecka S., Camu W., Meininger V., Dupré N., Dion P.A., et al. Mutation analysis of PFN1 in familial amyotrophic lateral sclerosis patients. Neurobiol Aging 2013, 34:1311.e1-1311.e2.
29. Dombroski B.A., Galasko D.R., Mata I.F., Zabetian C.P., Craig U.K., Garruto R.M., et al. C9orf72 hexanucleotide repeat expansion and Guam amyotrophic lateral sclerosis-Parkinsonism-dementia complex. JAMA Neurol 2013, 70:742-745.
30. Fallini C., Rouanet J.P., Donlin-Asp P.G., Guo P., Zhang H., Singer R.H., et al. Dynamics of survival of motor neuron (SMN) protein interaction with the mRNA-binding protein IMP1 facilitates its trafficking into motor neuron axons. Dev Neurobiol 2013 Jul 29, 10.1002/dneu.22111.
31. Farg M.A., Soo K.Y., Warraich S.T., Sundaramoorthy V., Blair I.P., Atkin J.D. Ataxin-2 interacts with FUS and intermediate-length polyglutamine expansions enhance FUS-related pathology in amyotrophic lateral sclerosis. Hum Mol Genet 2013, 22:717-728.
32. Figlewicz D.A., Krizus A., Martinoli M.G., Meininger V., Dib M., Rouleau G.A., et al. Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. Hum Mol Genet 1994, 3:1757-1761.
33. Fogel B.L., Pribadi M., Pi S., Perlman S.L., Geschwind D.H., Coppola G. C9ORF72 expansion is not a significant cause of sporadic spinocerebellar ataxia. Mov Disord 2012, 27:1832-1833.
34. Fratta P., Mizielinska S., Nicoll A.J., Zloh M., Fisher E.M., Parkinson G., et al. C9orf72 hexanucleotide repeat associated with amyotrophic lateral sclerosis and frontotemporal dementia forms RNA G-quadruplexes. Sci Rep 2012, 2:1016. 10.1038/srep01016.
35. Fratta P., Malik B., Gray A., La Spada A.R., Hanna M.G., Fisher E.M., et al. FUS is not dysregulated by the spinal bulbar muscular atrophy androgen receptor polyglutamine repeat expansion. Neurobiol Aging 2013, 34:1516.e17-1516.e19.
36. Gal J., Chen J., Barnett K.R., Yang L., Brumley E., Zhu H. HDAC6 regulates mutant SOD1 aggregation through two SMIR motifs and tubulin acetylation. JBiol Chem 2013, 288:15035-15045.
37. Gellera C., Tiloca C., Del Bo R., Corrado L., Pensato V., Agostini J., et al. Ubiquilin 2 mutations in Italian patients with amyotrophic lateral sclerosis and frontotemporal dementia. JNeurol Neurosurg Psychiatry 2013, 84:183-187.
38. González-Pérez P., Cirulli E.T., Drory V.E., Dabby R., Nisipeanu P., Carasso R.L., et al. Novel mutation in VCP gene causes atypical amyotrophic lateral sclerosis. Neurology 2012, 79:2201-2208.
39. Han J.H., Yu T.H., Ryu H.H., Jun M.H., Ban B.K., Jang D.J., et al. ALS/FTLD-linked TDP-43 regulates neurite morphology and cell survival in differentiated neurons. Exp Cell Res 2013, 319:1998-2005.
40. He J., Zhang Q.J., Lin Q.F., Chen Y.F., Lin X.Z., Lin M.T., et al. Molecular analysis of SMN1, SMN2, NAIP, GTF2H2, and H4F5 genes in 157 Chinese patients with spinal muscular atrophy. Gene 2013, 518:325-329.
41. Hirano M., Nakamura Y., Saigoh K., Sakamoto H., Ueno S., Isono C., et al. Mutations in the gene encoding p62 in Japanese patients with amyotrophic lateral sclerosis. Neurology 2013, 80:458-463.
42. Igari R., Wada M., Sato H., Hayashi Y.K., Nishino I., Kato T. Acase of inclusion body myopathy with Paget's disease of bone and frontotemporal dementia (IBMPFD) showing clinical features of motor neuron disease. Rinsho Shinkeigaku 2013, 53:458-464.
43. Iguchi Y., Katsuno M., Ikenaka K., Ishigaki S., Sobue G. Amyotrophic lateral sclerosis: an update on recent genetic insights. JNeurol 2013, 260:2917-2927.
44. Ikeda M., Hirano M., Shinoda K., Katsumata N., Furutama D., Nakamura K., et al. Triple a syndrome in Japan. Muscle Nerve 2013, 48:381-386.
45. Ingre C., Landers J.E., Rizik N., Volk A.E., Akimoto C., Birve A., et al. Anovel phosphorylation site mutation in profilin 1 revealed in a large screen of US, Nordic, and German amyotrophic lateral sclerosis/frontotemporal dementia cohorts. Neurobiol Aging 2013, 34:1708.e1-1708.e6.
46. Irwin D.J., McMillan C.T., Brettschneider J., Libon D.J., Powers J., Rascovsky K., et al. Cognitive decline and reduced survival in C9orf72 expansion frontotemporal degeneration and amyotrophic lateral sclerosis. JNeurol Neurosurg Psychiatry 2013, 84:163-169.
47. Ismail A., Cooper-Knock J., Highley J.R., Milano A., Kirby J., Goodall E., et al. Concurrence of multiple sclerosis and amyotrophic lateral sclerosis in patients with hexanucleotide repeat expansions of C9ORF72. JNeurol Neurosurg Psychiatry 2013, 84:79-87.
48. Jamrozik Z., Lugowska A., Gołebiowski M., Królicki L., Maczewska J., Kuźma-Kozakiewicz M. Late onset GM2 gangliosidosis mimicking spinal muscular atrophy. Gene 2013, 527:679-682.
49. Jang J.H., Kwon M.J., Choi W.J., Oh K.W., Koh S.H., Ki C.S., et al. Analysis of the C9orf72 hexanucleotide repeat expansion in Korean patients with familial and sporadic amyotrophic lateral sclerosis. Neurobiol Aging 2013, 34:1311.e7-1311.e9.
50. Kamada M., Izumi Y., Ayaki T., Nakamura M., Kagawa S., Kudo E., et al. Clinicopathologic features of autosomal recessive amyotrophic lateral sclerosis associated with optineurin mutation. Neuropathology 2013 Jul 29, 10.1111/neup.12051.
51. Kim H.J., Hong Y.B., Park J.M., Choi Y.R., Kim Y.J., Yoon B.R., et al. Mutations in the PLEKHG5 gene is relevant with autosomal recessive intermediate Charcot-Marie-Tooth disease. Orphanet J Rare Dis 2013, 8:104. 10.1186/1750-1172-8-104.
52. King A., Al-Sarraj S., Troakes C., Smith B.N., Maekawa S., Iovino M., et al. Mixed tau, TDP-43 and p62 pathology in FTLD associated with a C9ORF72 repeat expansion and p.Ala239Thr MAPT (tau) variant. Acta Neuropathol 2013, 125:303-310.
53. Klein C.J., Wu Y., Duan X., Middha S., Dawson B.D., Kocher J.P., et al. Novel SOD1 mutation discovered in atypical ALS by whole exome sequencing. JNeurol Neurosurg Psychiatry 2013, 84:943-944.
54. Kuijpers M., Yu K.L., Teuling E., Akhmanova A., Jaarsma D., Hoogenraad C.C. The ALS8 protein VAPB interacts with the ER-Golgi recycling protein YIF1A and regulates membrane delivery into dendrites. EMBO J 2013, 32:2056-2072.
55. Kumar R. Role of androgen receptor polyQ chain elongation in Kennedy's disease and use of natural osmolytes as potential therapeutic targets. IUBMB Life 2012, 64:879-884.
56. Kunze A., Lengacher S., Dirren E., Aebischer P., Magistretti P.J., Renaud P. Astrocyte-neuron co-culture on microchips based on the model of SOD mutation to mimic ALS. Integ Biol (Camb) 2013, 5:964-975.
57. Kuźma-Kozakiewicz M., Chudy A., Kaźmierczak B., Dziewulska D., Usarek E., Barańczyk-Kuźma A. Dynactin Deficiency in the CNS of humans with sporadic ALS and mice with genetically determined motor neuron degeneration. Neurochem Res 2013, (in press).
58. Lamarca N.H., Golden L., John R.M., Naini A., Vivo D.C., Sproule D.M. Diabetic ketoacidosis in an adult patient with spinal muscular atrophy type II: further evidence of extraneural pathology due to survival motor neuron 1 mutation?. JChild Neurol 2013, 28:1517-1520.
59. Lattante S., Conte A., Zollino M., et al. Contribution of major amyotrophic lateral sclerosis genes to the etiology of sporadic disease. Neurology 2012, 79:66-72.
60. Maiti D., Bhattacharya M., Yadav S. Isolated exon 8 deletion in type 1 spinal muscular atrophy with bilateral optic atrophy: unusual genetic mutation leading to unusual manifestation?. JPostgrad Med 2012, 58:294-295.
61. Martin L.J., Wong M. Aberrant regulation of DNA methylation in amyotrophic lateral sclerosis: a new target of disease mechanisms. Neurotherapeutics 2013, 10:722-733.
62. Mentula H.K., Tuovinen L., Penttilä S., Suominen T., Udd B., Palmio J. TARDBP mutations are not a frequent cause of ALS in Finnish patients. Acta Myol 2012, 31:134-138.
63. Minamiyama M., Katsuno M., Adachi H., Doi H., Kondo N., Iida M., et al. Naratriptan mitigates CGRP1-associated motor neuron degeneration caused by an expanded polyglutamine repeat tract. Nat Med 2012, 18:1531-1538.
64. Mori K., Lammich S., Mackenzie I.R., Forné I., Zilow S., Kretzschmar H., et al. hnRNP A3 binds to GGGGCC repeats and is a constituent of p62-positive/TDP43-negative inclusions in the hippocampus of patients with C9orf72 mutations. Acta Neuropathol 2013, 125:413-423.
65. Mori K., Weng S.M., Arzberger T., May S., Rentzsch K., Kremmer E., et al. The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS. Science 2013, 339:1335-1338.
66. Murray M.E., Bieniek K.F., Banks Greenberg M., Dejesus-Hernandez M., Rutherford N.J., van Blitterswijk M., et al. Progressive amnestic dementia, hippocampal sclerosis, and mutation in C9ORF72. Acta Neuropathol 2013, 126:545-554.
67. Niu C., Zhang J., Gao F., Yang L., Jia M., Zhu H., et al. FUS-NLS/Transportin 1 complex structure provides insights into the nuclear targeting mechanism of FUS and the implications in ALS. PLoS One 2012, 7:e47056. 10.1371/journal.pone.0047056.
68. Orlacchio A., Babalini C., Borreca A., Patrono C., Massa R., Basaran S., et al. SPATACSIN mutations cause autosomal recessive juvenile amyotrophic lateral sclerosis. Brain 2010, 133:591-598.
69. Padhi A.K., Jayaram B., Gomes J. Prediction of functional loss of human angiogenin mutants associated with ALS by molecular dynamics simulations. Sci Rep 2013, 3:1225.
70. Padhi A.K., Vasaikar S.V., Jayaram B., Gomes J. Fast prediction of deleterious angiogenin mutations causing amyotrophic lateral sclerosis. FEBS Lett 2013, 587:1762-1766.
71. Pamphlett R., Cheong P.L., Trent R.J., Yu B. Can ALS-associated C9orf72 repeat expansions be diagnosed on a blood DNA test alone?. PLoS One 2013 Jul 19, 8(7):e70007. 10.1371/journal.pone.0070007.
72. Paul P., de Belleroche J. The role of D-amino acids in amyotrophic lateral sclerosis pathogenesis: a review. Amino Acids 2012, 43:1823-1831.
73. Peeters K., Litvinenko I., Asselbergh B., Almeida-Souza L., Chamova T., Geuens T., et al. Molecular Defects in the motor adaptor BICD2 cause proximal spinal muscular atrophy with autosomal-dominant inheritance. Am J Hum Genet 2013 May 7, pii: S0002-9297(13)00174-2. 10.1016/j.ajhg.2013.04.013.
74. Piazzon N., Schlotter F., Lefebvre S., Dodré M., Méreau A., Soret J., et al. Implication of the SMN complex in the biogenesis and steady state level of the signal recognition particle. Nucleic Acids Res 2013, 41:1255-1272.
75. Pierson T.M., Torres P.A., Zeng B.J., Glanzman A.M., Adams D., Finkel R.S., et al. Juvenile-onset motor neuron disease caused by novel mutations in β-hexosaminidase. Mol Genet Metab 2013, 108:65-69.
76. Prause J., Goswami A., Katona I., Roos A., Schnizler M., Bushuven E., et al. Altered localization, abnormal modification and loss of function of sigma receptor-1 in amyotrophic lateral sclerosis. Hum Mol Genet 2013, 22:1581-1600.
77. Qin H., Wang W., Song J. ALS-causing P56S mutation and splicing variation on the hVAPB MSP domain transform its β-sandwich fold into lipid-interacting helical conformations. Biochem Biophys Res Commun 2013, 431:398-403.
78. Ratti A., Corrado L., Castellotti B., Del Bo R., Fogh I., Cereda C., et al. C9ORF72 repeat expansion in a large Italian ALS cohort: evidence of a founder effect. Neurobiol Aging 2012, 33:2528.e7-2528.e14.
79. Ravits J., Appel S., Baloh R.H., Barohn R., Brooks B.R., Elman L., et al. Deciphering amyotrophic lateral sclerosis: what phenotype, neuropathology and genetics are telling us about pathogenesis. Amyotroph Lateral Scler Front Degener 2013, 14(suppl 1):5-18.
80. Reddy K., Zamiri B., Stanley S.Y., Macgregor R.B., Pearson C.E. The disease-associated r(GGGGCC)n repeat from the C9orf72 gene forms tract length-dependent uni- and multimolecular RNA G-quadruplex structures. JBiol Chem 2013, 288:9860-9866.
81. Richardson K., Allen S.P., Mortiboys H., Grierson A.J., Wharton S.B., Ince P.G., et al. The effect of SOD1 mutation on cellular bioenergetic profile and viability in response to oxidative stress and influence of mutation-type. PLoS One 2013, 8(6):e68256. 10.1371/journal.pone.0068256.
82. Robberecht W., Philips T. The changing scene of amyotrophic lateral sclerosis. Nat Rev Neurosci 2013, 14:248-264.
83. Roberts B.L., Patel K., Brown H.H., Borchelt D.R. Role of disulfide cross-linking of mutant SOD1 in the formation of inclusion-body-like structures. PLoS One 2012, 7:e47838. 10.1371/journal.pone.0047838.
84. Sábado J., Casanovas A., Hernández S., Piedrafita L., Hereu M., Esquerda J.E. Immunodetection of disease-associated conformers of mutant cu/zn superoxide dismutase 1 selectively expressed in degenerating neurons in amyotrophic lateral sclerosis. JNeuropathol Exp Neurol 2013, 72:646-661.
85. Sabatelli M., Conte A., Zollino M. Clinical and genetic heterogeneity of amyotrophic lateral sclerosis. Clin. Genet. 2013, 83:408-416.
86. Scaramuzzino C., Monaghan J., Milioto C., Lanson N.A., Maltare A., Aggarwal T., et al. Protein arginine methyltransferase 1 and 8 interact with FUS to modify its sub-cellular distribution and toxicity invitro and invivo. PLoS One 2013, 8:e61576. 10.1371/journal.pone.0061576.
87. Seo J., Howell M.D., Singh N.N., Singh R.N. Spinal muscular atrophy: an update on therapeutic progress. Biochim Biophys Acta 2013, 1832:2180-2190.
88. Simpson C.L., Al-Chalabi A. Amyotrophic lateral sclerosis as a complex genetic disease. Biochim Byophys Acta 2006, 1762:973-985.
89. Takada L.T., Sha S.J. Neuropsychiatric features of C9orf72-associated behavioral variant frontotemporal dementia and frontotemporal dementia with motor neuron disease. Alzheimers Res Ther 2012, 4:38.
90. Takahashi Y., Fukuda Y., Yoshimura J., Toyoda A., Kurppa K., Moritoyo H., et al. ERBB4 mutations that Disrupt the neuregulin-ErbB4 pathway cause amyotrophic lateral sclerosis type 19. Am J Hum Genet 2013 Oct 8, pii: S0002-9297(13)00421-7. 10.1016/j.ajhg.2013.09.008.
91. Tan W., Naniche N., Bogush A., Pedrini S., Trotti D., Pasinelli P. Small peptides against the mutant SOD1/Bcl-2 toxic mitochondrial complex restore mitochondrial function and cell viability in mutant SOD1-mediated ALS. JNeurosci 2013, 33:11588-11598.
92. Tanaka F., Sone J., Atsuta N., Nakamura R., Doi H., Koyano S., et al. Personal genome analysis in amyotrophic lateral sclerosis. Brain Nerve 2013, 65:257-265.
93. Teyssou E., Takeda T., Lebon V., Boillée S., Doukouré B., Bataillon G., et al. Mutations in SQSTM1 encoding p62 in amyotrophic lateral sclerosis: genetics and neuropathology. Acta Neuropathol 2013, 125:511-522.
94. Thiyagarajan N., Ferguson R., Subramanian V., Acharya K.R. Structural and molecular insights into the mechanism of action of human angiogenin-ALS variants in neurons. Nat Commun 2012, 3:1121. 10.1038/ncomms2126.
95. Tiloca C., Ticozzi N., Pensato V., Corrado L., Del Bo R., Bertolin C., et al. Screening of the PFN1 gene in sporadic amyotrophic lateral sclerosis and in frontotemporal dementia. Neurobiol Aging 2013, 34:1517.e9-1517.e10.
96. Toichi K., Yamanaka K., Furukawa Y. Disulfide scrambling describes the oligomer formation of superoxide dismutase (SOD1) proteins in the familial form of amyotrophic lateral sclerosis. JBiol Chem 2013, 288:4970-4980.
97. Tortelli R., Conforti F.L., Cortese R., D'Errico E., Distaso E., Mazzei R., et al. Amyotrophic lateral sclerosis: a new missense mutation in the SOD1 gene. Neurobiol Aging 2013, 34:1709.e3-1709.e5.
98. Trippier P.C., Benmohammed R., Kirsch D.R., Silverman R.B. Substituted pyrazolones require N2 hydrogen bond donating ability to protect against cytotoxicity from protein aggregation of mutant superoxide dismutase 1. Bioorg Med Chem Lett 2012, 22:6647-6650.
99. van Blitterswijk M., DeJesus-Hernandez M., Rademakers R. How do C9ORF72 repeat expansions cause amyotrophic lateral sclerosis and frontotemporal dementia: can we learn from other noncoding repeat expansion disorders?. Curr Opin Neurol 2012, 25:689-700.
100. van Blitterswijk M., Vlam L., van Es M.A., van der Pol W.L., Hennekam E.A., Dooijes D., et al. Genetic overlap between apparently sporadic motor neuron diseases. PLoS One 2012, 7(11):e48983. 10.1371/journal.pone.0048983.
101. van Es M.A., Veldink J.H., Saris C.G., Blauw H.M., van Vught P.W., Birve A., et al. Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis. Nat Genet 2009, 41:1083-1087.
102. Vengoechea J., David M.P., Yaghi S.R., Carpenter L., Rudnicki S.A. Clinical variability and female penetrance in X-linked familial FTD/ALS caused by a P506S mutation in UBQLN2. Amyotroph Lateral Scler Front Degener 2013, 14:615-619.
103. Verma A., Tandan R. RNA quality control and protein aggregates in amyotrophic lateral sclerosis: a review. Muscle Nerve 2013, 47:330-338.
104. Watanabe S., Kaneko K., Yamanaka K. Accelerated disease onset with stabilized familial amyotrophic lateral sclerosis (ALS)-linked mutant TDP-43 proteins. JBiol Chem 2013, 288:3641-3654.
105. Weishaupt J.H., Waibel S., Birve A., Volk A.E., Mayer B., Meyer T., et al. Anovel optineurin truncating mutation and three glaucoma-associated missense variants in patients with familial amyotrophic lateral sclerosis in Germany. Neurobiol Aging 2013, 34:1516.e9-1516.e15.
106. Williams K.L., Fifita J.A., Vucic S., Durnall J.C., Kiernan M.C., Blair I.P., et al. Pathophysiological insights into ALS with C9ORF72 expansions. JNeurol Neurosurg Psychiatry 2013, 84:931-935.
107. Xu M., Zhu L., Liu J., Yang Y., Wu J.Y., Wang C. Characterization of β-domains in C-terminal fragments of TDP-43 by scanning tunneling microscopy. JStruct Biol 2013, 181:11-16.
108. Yamada K., Takado Y., Kato Y.S., Yamada Y., Ishiguro H., Wakamatsu N. Characterization of the mutant β-subunit of β-hexosaminidase for dimer formation responsible for the adult form of Sandhoff disease with the motor neuron disease phenotype. JBiochem 2013, 153:111-119.
109. Yokoyama J.S., Rosen H.J. Neuroimaging features of C9ORF72 expansion. Alzheimers Res Ther 2012, 4:45.
110. Zou Z.Y., Liu M.S., Li X.G., Cui L.Y. Screening of VCP mutations in Chinese amyotrophic lateral sclerosis patients. Neurobiol Aging 2013, 34:1519.e3-1519.e4.